In addition, there are a variety of novel serological molecular markers under exploration such as glypican-3, Golgi protein 73, α-L-fucosidase, osteopontin, microRNA, circulating tumor cells, circulating tumor DNA, exosomes, and circulating tumor DNA methylation. This evidence concerns the gene GPC3 and neoplasm.